Parmax Pharma Ltd — Important, 17-04-2026: Company Update

Parmax Pharma Limited has confirmed its compliance with share dematerialization regulations for the recent quarter. The company, through its Registrar and Share Transfer Agent, certified that all securities received for dematerialization were promptly mutilated, cancelled, and recorded in the depository's name. This process ensures accurate updating of shareholding records. Furthermore, it was confirmed that these dematerialized shares are listed on the stock exchanges where previous shares are also listed, assuring investors of proper administrative handling of their holdings.